Cipla Ltd. Probed for Anti-Competitive Practices

Published: May 09, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Fair trade regulator Competition Commission is probing allegation of anti-competitive practices against five entities related to pharmaceutical industry, including drug maker Cipla. The complaint has been filed against the five entities for allegedly engaging in anti-competition practices in granting stockist licence for medicines in Himachal Pradesh. The Competition Commission of India (CCI) is probing the allegation against Macleods Pharmaceutical, FDC Ltd, Cipla, Himachal Pradesh Society of Chemist & Druggist Alliance and its President. "...the Commission is of the opinion that there exists a prima facie, case to direct the Director General to cause an investigation into the matter," CCI said in an order dated April 11.

Help employers find you! Check out all the jobs and post your resume.

Back to news